Department of Biotechnology
Molecular Biotechnology
 Home | Organization | Staff  | Research | Core facilities | Courses | Directions | Links | Intranet

Bibliography — Amelie Eriksson Karlström

March 2012

38.
Lindgren, J., Ekblad, C., Abrahmsén, L. & Eriksson Karlström, A. (2012) “A native chemical ligation approach for combinatorial assembly of Affibody molecules”, ChemBioChem, in press.
37.
Rosik, D., Orlova, A.,  Malmberg, J., Altai, M., Varasteh, Z., Sandström, M., Eriksson Karlström, A., & Tolmachev, V. (2012) ”Direct comparison of indium-111-labeled 2-helix and 3-helix Affibody molecules for in vivo molecular imaging”, Eur. J. Nucl. Med. Mol. Imaging, in press
36.
Malmberg, J., Perols, A., Varasteh, Z., Altai, M., Braun, A., Sandström, M., Garske, U., Tolmachev, V., Orlova, A., Eriksson Karlström, A. (2012) ” Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labeled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts”, Eur. J. Nucl. Med. Mol. Imaging, 39, 481-492.
35.
Altai, M., Perols, A., Eriksson Karlström,  A., Sandström, M., Boschetti, F., Orlova,  A. & Tolmachev, V. (2011) ”Preclinical evaluation of anti-HER2 Affibody molecules site-specifically labeled with 111In using a maleimido derivative of NODAGA”, Nucl. Med. Biol., in press.
34.
Konrad, A., Eriksson Karlström, A. & Hober, S. (2011) “Covalent immunoglobulin labeling through a photoactivable synthetic Z domain” Bioconjug. Chem., 22, 2395-2403.
33.
Chen, S., Nyholm, L., Jokilaakso, N., Eriksson Karlström, A., Linnros, J., Smith, U. & Zhang, S.-L. (2011) “Current instability for silicon nanowire field-effect sensors operating in electrolyte with platinum as gate electrode”, Electrochem. Solid-State Lett., 14, J34-J37.
32.
Tolmachev, V., Altai, M., Sandström, M., Perols, A., Eriksson Karlström, A., Boschetti, F. & Orlova, A. (2011) ”Evaluation of a maleimido derivative of NOTA for site-specific labeling of Affibody molecules” Bioconjug. Chem., in press.
31.
Chen, S., Jokilaakso, N, Björk, P., Eriksson Karlström, A. & Zhang, S.-L. “A two-terminal silicon nanoribbon field-effect pH sensor” Appl. Phys. Lett., in press.
30.
Järver, P., Mikaelsson, C. & Eriksson Karlström, A. "Chemical synthesis and evaluation of a backbone-cyclized minimized 2-helix Z-domain” J. Pept. Sci., in press.
29.

Lindgren, J., Wahlström, A., Danielsson, J., Markova, N., Ekblad, C., Gräslund, A., Abrahmsén, L., Eriksson Karlström, A. & Wärmländer, S. K. T. S. (2010) “N-Terminal engineering of amyloid-β-binding Affibody molecules yields improved chemical synthesis and higher binding affinity”, Protein Sci., 19, 2319-2329.

28.

Orlova, A., Tran, T., Ekblad, T., Eriksson Karlström, A. & Tolmachev, V. (2010) ”186Re-maSGS-ZHER2:342, a potential Affibody conjugate for systemic therapy of HER2-expressing tumors”, Eur. J. Nucl. Med. Mol. Imaging, 37, 261-269.

27.
Ekblad, T., Orlova, A. Feldwisch, J., Wennborg, A., Eriksson Karlström, A. & Tolmachev, V. (2009) “Positioning of 99mTc-chelators influences radiolabeling, stability and biodistribution of Affibody molecules”, Bioorg. Med. Chem. Lett., 19, 3912-3914.
26.
Ekblad, T., Tolmachev, V., Orlova, A., Lendel, C., Abrahmsén, L. & Eriksson Karlström, A. (2009) Synthesis and chemoselective intramolecular cross-linking of a HER2-binding Affibody, Biopolymers, 92, 116-123.
25.
Tran, T., Ekblad, T., Orlova, A., Sandström, M., Feldwisch, J., Wennborg, A., Abrahmsén, L., Tolmachev, V. & Eriksson Karlström, A. (2008) “Effects of lysine-containing mercaptoacetyl-based chelators on the biodistribution of 99mTc-labeled anti-HER2 Affibody molecules”, Bioconjug. Chem., 19, 2568-2576.
24.
Ekblad, T., Tran, T., Orlova, A., Widström, C., Feldwisch, J., Abrahmsén, L., Wennborg, A., Eriksson Karlström, A. & Tolmachev, V. (2008) “Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake”, Eur. J. Nucl. Med. Mol. Imaging,35, 2245-55.
23.
Elfström, N., Eriksson Karlström, A. & Linnros, J. (2008) "Silicon nanoribbons for electrical detection of biomolecules", Nano Lett., 8, 945-949.
22.
Gry Björklund, M., Natanaelsson, C., Eriksson Karlström, A., Hao, Y. & Lundeberg, J. (2008) "Microarray analysis using disiloxyl 70mer oligonucleotides", Nucleic Acids Res., 36, 1334-1342..
21.
Tran, T., Engfeldt, T., Orlova, A., Sandström, M., Feldwisch, J., Abrahmsén, L., Wennborg, A., Tolmachev, V. & Eriksson Karlström, A. (2007)" 99mTc-maEEE-ZHER2:342, an Affibody molecule-based tracer for detection of HER2-expression in malignant tumors", Bioconjug. Chem., 18, 1956-1964.
20.
Elfström, N., Juhasz, R., Sychugov, I., Engfeldt, T., Eriksson Karlström, A. & Linnros, J. (2007) Surface charge sensitivity of silicon nanowires: Size dependence, Nano Lett., 7, 2608-2612.
19.
Orlova, A., Tran, T., Widström, C., Engfeldt, T., Eriksson Karlström, A. & Tolmachev, V. (2007) "Pre-clinical evaluation of [111In]-benzyl-DOTA-ZHER2:342, a potential agent for imaging of HER2 expression in malignant tumors", Int. J. Mol. Med., 20, 397-404.
18.
Engfeldt, T., Tran, T., Orlova, A., Widström, C., Feldwisch, J., Abrahmsén, L., Wennborg, A., Eriksson Karlström, A. & Tolmachev, V. (2007) "99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule", Eur. J. Nucl. Med. Mol. Imaging, 34, 1843-1853.
17.
Tran, T., Engfeldt, T., Orlova, A., Widström, C., Bruskin, A., Tolmachev, V. & Eriksson Karlström, A. (2007) "In vivo evaluation of cysteine-based chelators for attachment of 99mTc to tumor-targeting Affibody molecules", Bioconjug. Chem., 18, 549-558.
16.
Engfeldt, T., Orlova, A., Tran, T., Bruskin, A., Widström, C., Eriksson Karlström, A. & Tolmachev, V. (2007) "Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the (99m)Tc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence", Eur. J. Nucl. Med. Mol. Imaging, 34, 722-733.
15.
Renberg, B., Nordin, J., Merca, A., Uhlén, M., Feldwisch, J., Nygren, P.-Å. & Eriksson Karlström, A. (2007) "Affibody molecules in protein capture microarrays: evaluation of multidomain ligands and different detection formats", J. Proteome Res., 6, 171-179.
14.
Renberg, B., Shiroyama, I., Engfeldt, T., Nygren, P.-Å. & Eriksson Karlström, A. (2005) "Affibody protein capture microarrays: synthesis and evaluation of random and directed immobilization of affibody molecules", Anal. Biochem., 341, 334-343.
13.
Engfeldt, T., Renberg, B., Brumer, H., Nygren, P.-Å. & Eriksson Karlström, A. (2005) "Chemical synthesis of triple-labeled three-helix bundle binding proteins for specific fluorescent detection of unlabeled protein", ChemBioChem, 6, 1-8.
12.
Renberg, B., Nygren, P-Å., Eklund, M. & Eriksson Karlström, A. (2004) "Fluorescence resonance energy transfer-based detection of analytes using antiidiotypic affinity protein pairs", Anal. Biochem., 334, 72-80.
11.
Shim, H., Karlström, A., Touami, S. M., Fuller, R. P. & Barbas, C. F., III (2004) "Flow cytometric screening of aldolase catalytic antibodies" Bioorg. Med. Chem. Lett., 14, 4065-4068.
10.
Karlström, A. & Nygren, P.-Å. (2001) "Dual-labeling of a binding protein allows for specific fluorescence detection of native protein", Anal. Biochem., 295, 22-30.
9.
Karlström, A., Zhong, G., Rader, C., Larsen, N. A., Heine, A., Fuller, R., List, B., Tanaka, F., Wilson, I. A., Barbas, C. F., III, & Lerner. R. A. (2000) "Using antibody catalysis to study the outcome of multiple evolutionary trials of a chemical task" Proc. Natl. Acad. Sci. USA, 97, 3878-3883.
8.
Karlström, A., Rosenthal K. & Undén, A. (2000) "Study of the alkylation propensity of cations generated by acidolytic cleavage of protecting groups in Boc chemistry" J. Pept. Res., 55, 36-40.
7.
Rosenthal, K., Karlström, A. & Undén, A. (1997) "The 2,4-dimethylpent-3-yloxycarbonyl (Doc) group as a new, nucleophile-resistant protecting group for tyrosine in solid phase peptide synthesis" Tetrahedron Lett., 38, 1075-1078.
6.
Karlström, A. & Undén, A. (1997) "Association of cyclic peptides in aqueous solution measured by fluorescence quenching" Biopolymers, 41, 1-4.
5.
Karlström, A. & Undén, A. (1996) "Design of protecting groups for the ß- group of aspartic acid that minimize base-catalyzed aspartimide formation" Int. J. Peptide Prot. Res., 43, 305-311.
4.
Karlström, A. & Undén, A. (1996) "A new protecting group for aspartic acid that minimizes piperidine-catalyzed aspartimide formation for use in Fmoc solid phase peptide synthesis" Tetrahedron Lett. 37, 4243-4246.
3.
Karlström, A. & Undén, A. (1996) "Protection of the indole ring of tryptophan by the nucleophile-stable, acid-cleavable Nin-2,4-dimethylpent-3-yloxycarbonyl (Doc) protecting group" J. Chem. Soc., Chem. Commun. 1471-1472.
2.
Karlström, A. & Undén, A. (1996) "The Nim-2,4-dimethyl-3-pentyloxycarbonyl (Doc) group, a new nucleophile-resistant, HF-cleavable protecting group for histidine in peptide synthesis" J. Chem. Soc., Chem. Commun., 959-960.
1.
Karlström, A. & Undén, A. (1995) "The 2,4-dimethyl-3-pentyl ester as a new protecting group for aspartic acid that prevents base-catalyzed aspartimide formation in solid phase peptide synthesis" Tetrahedron Lett., 36, 3909-3912.
Last updated: 2012-03-07